कृपया अन्य खोज का प्रयास करें
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Ajay Gopal Royan | 43 | 2014 | Independent Director |
Clive A. Meanwell | 66 | 2021 | Independent Director |
Allan Roger Will | 69 | 2012 | Independent Chairman of the Board |
Harith Rajagopalan | 47 | 2010 | Co-Founder, CEO & Director |
Amy W. Schulman | 63 | 2018 | Independent Director |
Samuel Conaway | 59 | 2024 | Independent Director |
William Warren Bradley | 81 | 2017 | Independent Director |
Kelly Barnes | 57 | 2022 | Independent Director |
Marc William Elia | 47 | 2021 | Independent Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है